ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO1050

The Study on the Mechanism of SOCS1/STAT1 Regulate Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation


  • Bai, Jiuxu, Chinese PLA General Hospital, Beijing, China
  • Chen, Xiangmei, Chinese PLA General Hospital, Beijing, China

Glomerulonephritis (GN) is characterized by intraglomerular inflammation and is a major cause of end-stage renal disease.Inflammation plays a crucial role in the progress of mesangial proliferative glomerulonephritis (MsGN). The suppressor of cytokine signaling (SOCS) proteins which are inhibitors of cytokine signaling pathways unveiled an important mechanism for the negative regulation of the cytokine-induced JAK/STAT pathway. This study examined whether SOCS1 can regulate renal inflammation in MsGN models.


In Vivo: Rat (Thy 1.1 GN) and mouse (Habu GN) mesangial proliferative nephritis models were established. The expression of SOCS1, MHC class II, STAT1, inflammatory cells and cytokines were analyzed in MsGN modes. In Vitro: IFN-γ-stimulated mouse mesangial cells(MMCs)were transfected with SOCS1 plasmids. Meanwhile, we used STAT1 inhibitor fludarabine in IFN-γtreated MMCs. The expression of MHC class II, STAT1 and cytokines were analyzed.


Thy1.1 GN recapitulates the main features of human mesangial proliferative glomerular diseases, was generated. In addition, mouse GN was induced with Habu snake venom (HV). The number of macrophages and CD4 T cells increased significantly in glomeruli of MsGN models. Expression of IFN-γ, TNF-α, IL-12A and IL-12B increased significantly in the course of Thy 1.1 and Habu nephritis. MHC class II is expressed in mesangial cells of MsGN models. SOCS1 protein also showed a significant decrease and P-STAT1 increased significantly at early stage in MsGN models. It suggested that SOCS1/STAT1 participate in MsGN model progression. STAT1 inhibitor decreases renal inflammation and ameliorates glomerular lesions in Habu GN. The overexpression of SOCS1 repress MHC class II and STAT1 phosphorylation which is induced by IFN-γ in mesangial cells. STAT-1 inhibitor could inhibit IFN-γ-induced CIITA promoter activity and MHC class II significantly.


This study emphasizes the pivotal role of the SOCS1/STAT1 axis in regulating inflammation in mesangial proliferative glomerulonephritis. In addition, it demonstrates that SOCS1 is a critical regulator of cellular sensitivity to IFN-γ-induced CIITA and MHC class II expression in mesangial cells. The negative feedback between the expression of SOCS1 and inflammation may play an important role in the mesangial proliferative glomerulonephritis.


  • Government Support - Non-U.S.